Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Bach

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Molecular Metabolism|March 12, 2021
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonistKaare V Grunddal, Thi A Diep, Natalia Petersen, et al.
Science Advances|March 1, 2024
Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatmentNicole Fadahunsi, Jonas Petersen, Sophia Metz, et al.
Angewandte Chemie (International Ed. in English)|August 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein InteractionChunyu Lin, Dilip Narayanan, Marilia Barreca, et al.
ACS Pharmacology & Translational Science|October 19, 2023
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of Pellotine: A Hypnotic <i>Lophophora</i> AlkaloidChristian B M Poulie, Camilla B Chan, Aleksandra Parka, et al.
Redox Biology|March 9, 2025
Health position paper and redox perspectives - Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseasesAntonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
EMBO Molecular Medicine|May 1, 2020
A high-affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic painNikolaj R Christensen, Marta De Luca, Michael B Lever, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2021
GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domainUlrike Leurs, Anders B Klein, Ethan D McSpadden, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Molecular Metabolism|March 12, 2021
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonistKaare V Grunddal, Thi A Diep, Natalia Petersen, et al.
Science Advances|March 1, 2024
Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatmentNicole Fadahunsi, Jonas Petersen, Sophia Metz, et al.
Angewandte Chemie (International Ed. in English)|August 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein InteractionChunyu Lin, Dilip Narayanan, Marilia Barreca, et al.
ACS Pharmacology & Translational Science|October 19, 2023
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of Pellotine: A Hypnotic <i>Lophophora</i> AlkaloidChristian B M Poulie, Camilla B Chan, Aleksandra Parka, et al.
Redox Biology|March 9, 2025
Health position paper and redox perspectives - Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseasesAntonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
EMBO Molecular Medicine|May 1, 2020
A high-affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic painNikolaj R Christensen, Marta De Luca, Michael B Lever, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2021
GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domainUlrike Leurs, Anders B Klein, Ethan D McSpadden, et al.
Pageof 8